Skip to content
10-Q

Quarterly Report

GT Biopharma, Inc. GTBP

0001641172-25-010790

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 2.59M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $2.37M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $3.95M
Current Liabilities Q1 2025 · Mar 31, 2025 $3.64M
Current Liabilities Q1 2025 · Dec 31, 2024 $5.9M
Current Assets Q1 2025 · Mar 31, 2025 $2.66M
Current Assets Q1 2025 · Dec 31, 2024 $4.23M
Shares Diluted Q1 2025 · Mar 31, 2024 1.38M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$4.16M
Stockholders Equity Q1 2025 · Mar 31, 2024 $5.31M
Stockholders Equity Q1 2025 · Dec 31, 2023 $7.48M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.64
Eps Basic Q1 2025 · Mar 31, 2024 −$1.64
Sga Expense Q1 2025 · Mar 31, 2024 $2.31M
Rd Expense Q1 2025 · Mar 31, 2024 $777K
Net Income Q1 2025 · Mar 31, 2024 −$2.27M
Operating Income Q1 2025 · Mar 31, 2024 −$3.09M